Wells Fargo & Company MN cut its position in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 5.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 207,619 shares of the company’s stock after selling 10,877 shares during the quarter. Wells Fargo & Company MN owned about 0.21% of Encompass Health worth $13,852,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Principal Securities Inc. acquired a new stake in shares of Encompass Health during the fourth quarter worth $25,000. Benjamin F. Edwards & Company Inc. grew its holdings in Encompass Health by 360.2% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after purchasing an additional 317 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new stake in Encompass Health in the fourth quarter worth $30,000. GAMMA Investing LLC acquired a new stake in Encompass Health in the fourth quarter worth $33,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in Encompass Health in the third quarter worth $35,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Encompass Health
In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the completion of the sale, the insider now owns 18,594 shares in the company, valued at approximately $1,580,861.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, EVP John Patrick Darby sold 14,543 shares of Encompass Health stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the sale, the executive vice president now owns 84,773 shares of the company’s stock, valued at approximately $7,115,845.62. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 10,000 shares of Encompass Health stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $85.02, for a total value of $850,200.00. Following the completion of the sale, the insider now directly owns 18,594 shares of the company’s stock, valued at approximately $1,580,861.88. The disclosure for this sale can be found here. Insiders have sold a total of 69,519 shares of company stock worth $5,816,091 over the last three months. 2.10% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on EHC shares. Mizuho raised their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Barclays raised their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, April 25th. Truist Financial raised their price target on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Raymond James reissued a “strong-buy” rating and set a $95.00 target price (up from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average price target of $92.00.
Check Out Our Latest Stock Analysis on EHC
Encompass Health Price Performance
Encompass Health stock opened at $86.39 on Friday. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $87.94. The company’s 50 day moving average price is $83.02 and its two-hundred day moving average price is $74.74. The stock has a market cap of $8.70 billion, a P/E ratio of 23.35, a P/E/G ratio of 1.33 and a beta of 0.92. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 1.14.
Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter in the previous year, the firm earned $0.88 earnings per share. The business’s revenue was up 13.4% on a year-over-year basis. On average, equities analysts predict that Encompass Health Co. will post 4.1 earnings per share for the current year.
Encompass Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.69%. The ex-dividend date is Monday, July 1st. Encompass Health’s dividend payout ratio is 16.22%.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
